Rotem Petranker
Scientific AdvisorRotem Petranker is a psychedelics researcher with a particular emphasis on microdosing, therapy, research methods and research ethics.
As part of my research, I have gained extensive expertise in navigating the regulatory landscapes of Health Canada and the FDA and a strong background in designing rigorous clinical trial research methodologies. I founded the Canadian Centre for Psychedelic Science in 2018, established the Psychedelic Science Research Program at the University of Toronto in 2019, and, more recently, played a central role in founding the International Consortium for Psychedelic Research Centers. I have published many papers on microdosing, including some of the largest samples in the literature (e.g.,Petranker et al., 2020). I am currently running the first clinical trial examining the impact of microdosing psilocybin on Major Depressive Disorder.